Skip Navigation


IJE Advance Access originally published online on April 22, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/3/614    most recent
dyh188v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brindle, P. M
Right arrow Articles by Holt, T. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brindle, P. M
Right arrow Articles by Holt, T. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Volume 33, Number 3, pp. 614-615
IJE vol.33 no.3 © International Epidemiological Association 2004; all rights reserved.


Letter to the Editor

Cardiovascular risk assessment—time to look beyond cohort studies

Peter M Brindle1 and Tim A Holt2

1 Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK
2 Department of Primary Health Care Studies, University of Warwick, Coventry CV4 7AL, UK

The first 10% of the full text of this article appears below.

Sirs—In the April issue of the International Journal of Epidemiology, Hans-Werner Hense provides a comprehensive treatise on the current state of cardiovascular risk assessments.1 He highlights the problems with using risk scores derived from epidemiological data to target preventive treatment at highest risk individuals. His comments add to the growing literature recognizing that the risk assessment methods used in current treatment guidelines do not provide an accurate assessment of an individual's true risk.2,3 Hense identifies some of these potential sources of inaccuracy: the variation of cardiovascular risk between populations, using predictions based on assessment of risk factors at one occasion only, the confusing variety of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. T. Cooney, A. L. Dudina, and I. M. Graham
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1209 - 1227.
[Abstract] [Full Text] [PDF]